Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 3, Pages 363
Publisher
MDPI AG
Online
2019-03-14
DOI
10.3390/cancers11030363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
- (2019) Laura Cantini et al. NUCLEIC ACIDS RESEARCH
- Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
- (2019) Yuan Chun Ding et al. Oncotarget
- MicroRNAs as Clinical Biomarkers and Therapeutic Tools in Perioperative Medicine
- (2018) Simone Kreth et al. ANESTHESIA AND ANALGESIA
- The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
- (2018) Shavira Narrandes et al. BMC CANCER
- Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
- (2018) Christoph Engel et al. BMC CANCER
- Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
- (2018) Ricardo L. B. Costa et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene expression in triple-negative breast cancer in relation to survival
- (2018) Shuyang Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA-493 is a prognostic factor in triple-negative breast cancer
- (2018) Ling Yao et al. CANCER SCIENCE
- MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells
- (2018) Jiahui Chu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Novel prognostic and predictive microRNA targets for triple-negative breast cancer
- (2018) Gulisa Turashvili et al. FASEB JOURNAL
- Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
- (2018) Janaki Ramaiah Mekala et al. GENE
- miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes
- (2018) Paolo Uva et al. International Journal of Medical Sciences
- MicroRNAs in regulation of triple-negative breast cancer progression
- (2018) Dominika Piasecka et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer
- (2018) Tiffany A. Traina et al. JOURNAL OF CLINICAL ONCOLOGY
- miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1
- (2018) Xin Wang et al. ONCOLOGY REPORTS
- Differential Expression of MicroRNAs in Breast Cancers from Four Different Ethnicities
- (2018) Jennifer Pollard et al. PATHOBIOLOGY
- Loss of PTEN in high grade advanced stage triple negative breast ductal cancers in African American women
- (2018) Farhan Khan et al. PATHOLOGY RESEARCH AND PRACTICE
- Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
- (2018) Man-Xiu Li et al. OncoTargets and Therapy
- Racial/ethnic disparities in de novo metastases sites and survival outcomes for patients with primary breast, colorectal, and prostate cancer
- (2018) Tomi Akinyemiju et al. Cancer Medicine
- Genetic Markers in Triple-Negative Breast Cancer
- (2018) Zuzana Sporikova et al. Clinical Breast Cancer
- Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis
- (2018) Pengzhi Dong et al. Biomed Research International
- Identification of FOXM1 as a specific marker for triple‑negative breast cancer
- (2018) Yanli Tan et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Dysregulation of microRNAs in triple-negative breast cancer
- (2017) Sylwia Paszek et al. Ginekologia Polska
- Prognostic value of microRNA-9 and microRNA-155 expression in triple-negative breast cancer
- (2017) Min Hye Jang et al. HUMAN PATHOLOGY
- MicroRNAs in the prognosis of triple-negative breast cancer
- (2017) Lingshuang Lü et al. MEDICINE
- A New Gene Expression Signature for Triple-Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy
- (2017) Sandra K Santuario-Facio et al. MOLECULAR MEDICINE
- MicroRNA‑27a promotes tumorigenesis via targeting AKT in triple negative breast cancer
- (2017) Jing Wu et al. Molecular Medicine Reports
- Screening and identification of potential biomarkers in triple-negative breast cancer by integrated analysis
- (2017) Jilong Guo et al. ONCOLOGY REPORTS
- miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers
- (2017) Insaf Fkih M’hamed et al. PATHOLOGY & ONCOLOGY RESEARCH
- PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
- (2017) Nandini Dey et al. PHARMACOLOGY & THERAPEUTICS
- Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
- (2017) Zhihao Zeng et al. YONSEI MEDICAL JOURNAL
- Targeting the androgen receptor in triple-negative breast cancer: current perspectives
- (2017) Alain Mina et al. OncoTargets and Therapy
- microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression
- (2017) Guang-Cheng Guo et al. CELLULAR ONCOLOGY
- microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis
- (2017) Farah J. Nassar et al. Scientific Reports
- Targeting MicroRNAs in Cancer Gene Therapy
- (2017) Weidan Ji et al. Genes
- MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis
- (2017) Yanli Liu et al. PLoS One
- DUSP1 promoter methylation in peripheral blood leukocyte is associated with triple-negative breast cancer risk
- (2017) Jing Li et al. Scientific Reports
- Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer
- (2016) Zhongxing Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer
- (2016) Jiawei Chen et al. BMC CANCER
- Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer
- (2016) Eriko Tokunaga et al. BREAST
- miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer
- (2016) Elvira D'Ippolito et al. CANCER RESEARCH
- Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value
- (2016) Yi-Zhou Jiang et al. CANCER RESEARCH
- Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer
- (2016) Aiyu Zhu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome
- (2016) Rhiannon K Beckers et al. HISTOPATHOLOGY
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer
- (2016) Bisrat G. Debeb et al. JNCI-Journal of the National Cancer Institute
- MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer
- (2016) Lei Huo et al. MODERN PATHOLOGY
- MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer
- (2016) Xin Xu et al. Oncotarget
- Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women
- (2016) Bruna Sugita et al. Oncotarget
- MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase
- (2016) Recep Bayraktar et al. Oncotarget
- miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer
- (2016) Bisrat G. Debeb et al. JNCI-Journal of the National Cancer Institute
- MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
- (2016) Lingmi Hou et al. MEDICAL SCIENCE MONITOR
- Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer
- (2016) Seema Thakur et al. PLoS One
- MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1
- (2016) Xu Sun et al. PLoS One
- Genetics of breast cancer: a topic in evolution
- (2015) S. Shiovitz et al. ANNALS OF ONCOLOGY
- Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer
- (2015) Shaham Beg et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognostic impact of age in different molecular subtypes of breast cancer
- (2015) Cornelia Liedtke et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer
- (2015) Peng Liu et al. CANCER LETTERS
- Beyond BRCA: New hereditary breast cancer susceptibility genes
- (2015) P. Economopoulou et al. CANCER TREATMENT REVIEWS
- Differences in Breast Cancer Stage at Diagnosis and Cancer-Specific Survival by Race and Ethnicity in the United States
- (2015) Javaid Iqbal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNA let-7: Regulation, single nucleotide polymorphism, and therapy in lung cancer
- (2015) Zhe An et al. Journal of Cancer Research and Therapeutics
- Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
- (2015) Fergus J. Couch et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
- (2015) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
- (2015) William M. Sikov et al. JOURNAL OF CLINICAL ONCOLOGY
- TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
- (2015) Steven J. Isakoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer
- (2015) Lyndsay V. Rhodes et al. Oncotarget
- Prognostic and predictive value of PDL1 expression in breast cancer
- (2015) Renaud Sabatier et al. Oncotarget
- MicroRNA Regulation of Human Breast Cancer Stem Cells
- (2015) Yohei Shimono et al. Journal of Clinical Medicine
- Abstract 2368: Differential gene expression in key oncolytic pathways between node-matched Caucasian-American, African-American and East African triple-negative breast cancer patients
- (2015) Julie Getz et al. CANCER RESEARCH
- Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis
- (2015) Jinsong He et al. PLoS One
- microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
- (2015) Pierluigi Gasparini et al. Oncotarget
- MicroRNA let-7a: a novel therapeutic candidate in prostate cancer
- (2014) Jun Li et al. ASIAN JOURNAL OF ANDROLOGY
- Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers
- (2014) Renata A Rawlings-Goss et al. BMC Medical Genomics
- MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
- (2014) Brock Humphries et al. CARCINOGENESIS
- A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients
- (2014) K. Kleivi Sahlberg et al. CLINICAL CANCER RESEARCH
- High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation
- (2014) Guizhi Dong et al. MEDICAL ONCOLOGY
- Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report
- (2014) Agnieszka Kolacinska et al. MOLECULAR BIOLOGY REPORTS
- MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
- (2014) Mao Ouyang et al. PLoS One
- A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
- (2014) Songjie Shen et al. PLoS One
- AG1478 inhibits the migration and invasion of cisplatin-resistant human lung adenocarcinoma cells via the cell cycle regulation by matrix metalloproteinase-9
- (2014) LI MA et al. Oncology Letters
- Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort
- (2013) Rachel Greenup et al. ANNALS OF SURGICAL ONCOLOGY
- Detection methods for microRNAs in clinic practice
- (2013) Mariàngels de Planell-Saguer et al. CLINICAL BIOCHEMISTRY
- Molecular Pathways: PI3K Pathway Targets in Triple-Negative Breast Cancers
- (2013) V. Gordon et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Deregulated Serum Concentrations of Circulating Cell-Free MicroRNAs miR-17, miR-34a, miR-155, and miR-373 in Human Breast Cancer Development and Progression
- (2013) C. Eichelser et al. CLINICAL CHEMISTRY
- Action on obesity: comprehensive care for all
- (2013) J. Wass et al. CLINICAL MEDICINE
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker
- (2013) Dennis C. Sgroi et al. JNCI-Journal of the National Cancer Institute
- MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis
- (2013) Yong Liu et al. MEDICAL SCIENCE MONITOR
- Emerging patterns of somatic mutations in cancer
- (2013) Ian R. Watson et al. NATURE REVIEWS GENETICS
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
- (2013) W Kong et al. ONCOGENE
- Cigarette Smoking and Risk of Breast Cancer in a New Zealand Multi-Ethnic Case-Control Study
- (2013) Fiona McKenzie et al. PLoS One
- Differentially Expressed Transcripts and Dysregulated Signaling Pathways and Networks in African American Breast Cancer
- (2013) Paul A. Stewart et al. PLoS One
- Epithelial-mesenchymal transition and its regulators are major targets of triple-negative breast cancer
- (2013) Ala-Eddin Al Moustafa Cell Adhesion & Migration
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
- (2012) M. T. Di Martino et al. CLINICAL CANCER RESEARCH
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008
- (2012) Freddie Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Role of Hormone Receptors in Ovarian Cancer
- (2012) Dong Zhao et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis
- (2012) MASATO KOMATSU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
- (2012) Patrick J. Roberts et al. JNCI-Journal of the National Cancer Institute
- Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy
- (2012) I-Min Lee et al. LANCET
- Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
- (2012) Claudia Piovan et al. Molecular Oncology
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
- (2012) Min-Bin Chen et al. PLoS One
- Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN
- (2012) Mingli Han et al. PLoS One
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival
- (2011) Jianxiang Chi et al. Biology Direct
- FOXA1: master of steroid receptor function in cancer
- (2011) Michael A Augello et al. EMBO JOURNAL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of microRNA-145 for therapeutic application in breast cancer
- (2011) Seok-Jun Kim et al. JOURNAL OF CONTROLLED RELEASE
- Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
- (2011) Junqing Chen et al. MEDICAL ONCOLOGY
- Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells
- (2011) Mingli Han et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Practical implications of gene-expression-based assays for breast oncologists
- (2011) Aleix Prat et al. Nature Reviews Clinical Oncology
- MicroRNA-mediated breast cancer metastasis: from primary site to distant organs
- (2011) L Wang et al. ONCOGENE
- A Perspective on Cancer Cell Metastasis
- (2011) C. L. Chaffer et al. SCIENCE
- miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer
- (2011) S. Stinson et al. Science Signaling
- The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
- (2010) Michael Knauer et al. BREAST CANCER RESEARCH AND TREATMENT
- Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
- (2010) S. Asaga et al. CLINICAL CHEMISTRY
- Somatic mutations in cancer prognosis and prediction: lessons from TP53 and EGFR genes
- (2010) Magali Olivier et al. CURRENT OPINION IN ONCOLOGY
- miR-10b Targets Tiam1
- (2010) Charlotte H. Moriarty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
- (2010) B. A. Virnig et al. JNCI-Journal of the National Cancer Institute
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
- (2010) Li Ma et al. NATURE CELL BIOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers
- (2010) C. G. Fedele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coverage Policy Development for Personalized Medicine: Private Payer Perspectives on Developing Policy for the 21-Gene Assay
- (2010) Julia R. Trosman et al. Journal of Oncology Practice
- T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy
- (2009) Henry G. Kaplan et al. Breast Journal
- Sex Hormone Levels, Breast Cancer Risk, and Cancer Receptor Status in Postmenopausal Women: the ORDET Cohort
- (2009) S. Sieri et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- MicroRNAs As Novel Regulators of Angiogenesis
- (2009) Yajaira Suárez et al. CIRCULATION RESEARCH
- Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
- (2009) Farrah Kassam et al. Clinical Breast Cancer
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis
- (2009) Christoph A Gebeshuber et al. EMBO REPORTS
- Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
- (2009) Florian Heitz et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression
- (2009) Mick D. Edmonds et al. INTERNATIONAL JOURNAL OF CANCER
- p53 as a Specific Prognostic Factor in Triple-negative Breast Cancer
- (2009) B. J. Chae et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer
- (2009) Aye Aye Thike et al. MODERN PATHOLOGY
- Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
- (2009) Henry T. Lynch et al. Molecular Oncology
- High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
- (2008) Biyun Qian et al. BREAST CANCER RESEARCH AND TREATMENT
- The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
- (2008) Stella Mook et al. BREAST CANCER RESEARCH AND TREATMENT
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Triple-negative breast cancer
- (2008) Gert Stockmans et al. CURRENT OPINION IN ONCOLOGY
- What is triple-negative breast cancer?
- (2008) William J. Irvin et al. EUROPEAN JOURNAL OF CANCER
- How basal are triple-negative breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Endogenous human microRNAs that suppress breast cancer metastasis
- (2008) Sohail F. Tavazoie et al. NATURE
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
- (2008) Qihong Huang et al. NATURE CELL BIOLOGY
- A microRNA DNA methylation signature for human cancer metastasis
- (2008) A. Lujambio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
- (2008) L.-X. Yan et al. RNA
- Changes in miRNA expression in solid tumors: An miRNA profiling in melanomas
- (2008) Viktor Molnár et al. SEMINARS IN CANCER BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now